For the Inventor, By the Inventor

Enter assignee name

Monmouth Junction, NJ, United States of America

Signum Biosciences, Inc.

USPTO Granted Patents = 19

CIPO Patents = 8

EPO Patents = 8

Trademarks = 5

Forward Citations = 51

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Maxwell Stock (16 out of 16 patents)

Jeffry B Stock (16 out of 17 patents)

Michael Voronkov (12 out of 20 patents)

4. Seung-Yub Lee (7 out of 8 patents)

5. Eduardo Perez (7 out of 7 patents)

6. Joel Gordon (7 out of 7 patents)

7. Jose Fernandez (5 out of 5 patents)

8. Keshava Rapole (5 out of 8 patents)

9. Shuyi Chen (5 out of 5 patents)

10. Zhu Li (4 out of 4 patents)

11. Haoming Gu (4 out of 4 patents)

12. Jinglong Chen (4 out of 4 patents)

13. Jason Healy (3 out of 3 patents)

14. Scott Bradley Vafai (3 out of 29 patents)

15. Gregory Stock (3 out of 3 patents)

19 patents: Sort by Forward Citations

1. 11802107 - Compounds and methods of use (2023-10-31),

2. 11518738 - Compounds and methods of use (2022-12-06),

3. 10975023 - Compounds and methods of use (2021-04-13),

4. 10912812 - Methods for preparing botanical extracts (2021-02-09),

5. 10583119 - Compounds, compositions and methods for making the same (2020-03-10),

6. 10314817 - Tryptamide compositions and methods of use (2019-06-11),

7. 10314802 - Isoprenyl compounds and methods thereof (2019-06-11),

8. 10117904 - Use of anti-bacterial agents for the treatment of epithelial-related conditions (2018-11-06),

9. 9744147 - Isoprenyl compounds and methods thereof (2017-08-29),

10. 9486441 - Compounds, compositions and methods for making the same (2016-11-08),

11. 9415026 - Use of anti-bacterial agents for the treatment of epithelial-related conditions (2016-08-16),

12. 9376383 - Isoprenyl compounds (2016-06-28),

13. 8461204 - Cysteinyl compounds, compositions and methods of use (2013-06-11),

14. 8372884 - Isoprenyl compounds and methods thereof (2013-02-12),

15. 8338648 - Topical compositions and methods for epithelial-related conditions (2012-12-25),

Signum Biosciences, Inc. is a biotechnology company focused on developing innovative therapies using small molecule technology. Their mission is to improve human health by identifying and targeting key signaling pathways implicated in various diseases, such as inflammation and aging. Signum Biosciences leverages its expertise in molecular biology, genetics, and bioinformatics to discover and develop novel drug candidates with the potential to address unmet medical needs. Through strategic collaborations and clinical partnerships, they aim to accelerate the translation of their discoveries into safe and effective therapeutics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

19 Patents

#9 in Monmouth Junction, NJ

#643 in New Jersey

#16,597 in US

#31,681 in the World

Monmouth Junction, NJ, United States of America

Signum Biosciences, Inc.

Forward Citations = 51

25 inventors:

Maxwell Stock (16 out of 16 patents)

Jeffry B Stock (16 out of 17 patents)

Michael Voronkov (12 out of 20 patents)

4. Seung-Yub Lee (7 out of 8 patents)

5. Eduardo Perez (7 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…